Business Development

Are you a service provider to the pharma/bio industry? Find out the invaluable steps you can take to develop your business. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in business development and marketing to exchange ideas on best practice and share case studies on business development, strategy, advertising and marketing for the pharmaceutical, biotechnology and healthcare sectors.
 


The Developing Life Sciences Ecosystem is Driving Changes in the Profile of Boards - Pharma IQ

As biotech/emerging companies develop and their assets/operations approach commercial maturity we see a change in the skill mix sought by Chairs. Full Article »


Events related to this topic:

Merck KGaA: Building a Strategic Partnership with your CMO

Contributor: Sascha Basten
Posted: 7/10/2012


Merck KGaA: Building a Strategic Partnership with your CMO - Sascha Basten

Sascha Basten, Associate Director, External Transfers and Product Introductions, MS-TechOps / External Maufacturing at Merck KGaA, spoke to Pharma IQ at the GPCM Summit 2012 and explained the key principles behind a successful relationship between their organisation and CMO, while looking ahead to possible challenges and opportunities for both sides of the partnership. Full Video »


Events related to this topic:

4 Big Buckets on Pharmaceutical Social Media Marketing and Control - Andrea Charles

If you can't talk are you listening? A big challenge for many social media marketers and business development personnel is control. In this Pharma IQ podcast we address common issues companies are facing engaging in heavily regulated industries like Pharma. Shirley Williams from Social Media Pearls delivers her top tips for integrating social media into your campaign and recommends the best social media tools for increasing efficiency. Full Podcast »


Events related to this topic:

The Race to Develop Adalimumab Biosimilars

Contributor: Peter Norman
Posted: 11/17/2014


The Race to Develop Adalimumab Biosimilars - Peter Norman

With a market of more than $10 billion, competition is heating up to get a piece of the world's best selling drug, Humira. In this column, Peter Norman examines the biosimilars currently in trials and looks at the potential impact of these drugs on the vast revenues of this drug. Full Column »


Events related to this topic:

50 Movers and Shakers in BioBusiness 2014

As the global biobusiness sector undergoes rapid transformation, there are growing opportunities to tap. This report identifies 50 inspirational women in biobusiness in the UK who are challenging the status quo and bringing better health to people around the world. This report includes experienced leaders and rising stars. Full Whitepaper »


Events related to this topic:



Advertise With Us

Join the Pharmas IQ Community